ATRC · AtriCure, Inc.
Market Cap
$2.62B
Shares
50.87M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$51.52
Open$52.03
Day$51.03–52.53
52W close$25.86–52.59
Avg vol 30d808K
Short int3.9M · 7.7% float · 6.1d
Short vol48%
Last earningsJul 23, 2026
DataJan 2020–Sep 2026
Filing10-Q · Jul 27
Up next
Next earnings call
Oct 17, 2026
Est · unconfirmed
· in 6 wks
filed Jul 27, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$569.62M
Trailing 12 months
Net income (TTM)
$10.55M
Trailing 12 months
Revenue growth YoY
+12.8%
Year over year
Operating margin
2.3%
Trailing 12 months
P / E (TTM)
245.3
Trailing earnings · reciprocal yield 0.4%
FCF yield
2.0%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.4%
Year over year · more shares
Price change (1Y)
+44.5%
Trailing year
Short interest
7.7%
Latest settlement · 6.1 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
High
Market backdrop
VIX 14.5 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+49%
above
Price vs 50-day avg
+29%
above
RSI (14)
74
overbought
MACD trend
Positive
52-week position
96%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+24%
trailing
6-month return
+69%
trailing
YTD return
+30%
this year
Relative strength
+54%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $40 › 200d $35 — 50d above 200d
Institutional flow
Accumulating
+13% holders QoQ · +55 funds added
Insider flow
Distributing
Net -$2.1M over 90 days · 100% sells
Short interest
Rising
7.71% of float · ▲ +1.5% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
254 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
+15%
Y/Y
Gross margin
199%
contracting
EPS growth
+75%
Y/Y
Free cash flow
$48.3M
Valuation
P/E 245.3
rich
Balance sheet
$28.3M
net cash
Quant / Vol
risk profile
Volatility
47%
annualized · 1-yr
Max drawdown
−39%
past year
ATR
3.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the Earnings Call filed Dec 31, 2021
Revenue
· full year 2022
$315M – $330M
Overall business growth
· 2022
15% – 20%
Guided vs delivered
· last 1 settled
Revenue
full year 2022
guided $315M – $330M
$330.38M
Beat +2.4%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+49%
Bullish
Price vs 50-day avg
+29%
Bullish
RSI (14)
74
Bearish
MACD trend
Positive
Bullish
52-week position
96%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $40 › 200d $35 — 50d above 200d
Institutional flow
Accumulating
+13% holders QoQ · +55 funds added
Insider flow
Distributing
Net -$2.1M over 90 days · 100% sells
Short interest
Rising
7.71% of float · ▲ +1.5% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
254 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $26
Now $52 · 96%
Range high $53
vs 200-day avg +49%
vs 50-day avg +29%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ATRC
this stock
AtriCure, Inc.
|
$2.62B | +30.2% | +15.4% | 245.3 | 7.7% |
|
ISRG
Intuitive Surgical Inc
|
$129.55B | -35.3% | +20.5% | 42.1 | 2.0% |
|
BDX
Becton Dickinson & Co
|
$50.32B | — | +8.2% | — | 3.4% |
|
MDLN
Medline Inc.
|
$48.11B | -12.9% | +11.5% | — | 2.8% |
|
ALC
Alcon Inc
|
$34.08B | -10.5% | +10.5% | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ATRC | +6.1% | +24.5% | +69.3% | +6.6% | +30.2% |
| SPY | +0.1% | -0.4% | +15.1% | +0.4% | +12.9% |
| vs SPY | +6.0% | +24.9% | +54.1% | +6.2% | +17.3% |
Key facts
CIK
1323885
CUSIP
04963C209
13F (30d)
194 filings
192 filers
Visit website
Investor relations